Bridgebio Pharma Inc (BBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -322,446 | -166,555 | -732,938 | -538,303 | -353,366 |
| Depreciation Amortization | 5,984 | 3,005 | 11,401 | 3,999 | 5,657 |
| Accounts receivable | -115,040 | -65,782 | -134,722 | N/A | -72,146 |
| Accounts payable and accrued liabilities | -9,026 | -7,170 | 26,609 | 9,084 | 16,516 |
| Other Working Capital | -134,034 | -124,741 | -51,064 | -100,675 | -96,744 |
| Other Operating Activity | 306,182 | 163,964 | 434,804 | 236,405 | 220,167 |
| Operating Cash Flow | $-268,380 | $-197,279 | $-445,910 | $-389,490 | $-279,916 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -512 | -69 | -1,097 | -1,064 | -594 |
| Purchase Of Investment | -63,937 | -52,666 | -28,197 | -10,876 | -7,908 |
| Sale Of Investment | 39,600 | 10,000 | 11,000 | 8,000 | 0 |
| Purchase Sale Intangibles | N/A | N/A | -8,495 | -8,495 | -6,095 |
| Other Investing Activity | 0 | 0 | -6,193 | -6,193 | -6,095 |
| Investing Cash Flow | $-24,849 | $-42,735 | $-24,487 | $-10,133 | $-14,597 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 632,500 | 632,500 | 575,000 | 575,000 | 575,000 |
| Debt Repayment | N/A | N/A | -459,000 | -459,000 | -459,000 |
| Common Stock Issued | 33,278 | 28,055 | 34,149 | 20,937 | 12,917 |
| Common Stock Repurchased | -218,344 | -86,574 | -62,502 | -55,072 | -52,047 |
| Other Financing Activity | -46,309 | -24,089 | 271,646 | 279,610 | 285,499 |
| Financing Cash Flow | $401,125 | $549,892 | $359,293 | $361,475 | $362,369 |
| Beginning Cash Position | 572,140 | 572,140 | 683,244 | 683,244 | 683,244 |
| End Cash Position | 680,036 | 882,018 | 572,140 | 645,096 | 751,100 |
| Net Cash Flow | $107,896 | $309,878 | $-111,104 | $-38,148 | $67,856 |
| Free Cash Flow | |||||
| Operating Cash Flow | -268,380 | -197,279 | -445,910 | -389,490 | -279,916 |
| Capital Expenditure | -512 | -69 | -1,097 | -1,064 | -594 |
| Free Cash Flow | -268,892 | -197,348 | -447,007 | -390,554 | -280,510 |